SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Monicayang
Lv1
20 积分
2023-08-31 加入
最近求助
最近应助
互助留言
505 POSTER Preliminary results of a phase II clinical trial of the anti EGFR monoclonal antibody Nimotuzumab in combination with whole brain radiation therapy in patients diagnosed with advanced non-small cell lung cancer tumors unresectable brain metastases
2天前
已关闭
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
10天前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
10天前
已完结
The price and value of therapeutic synergy in liver cancer
10天前
已完结
Genetic regulatory and biological implications of the 10q24.32 schizophrenia risk locus
11天前
已完结
Genome-wide meta-analysis, functional genomics and integrative analyses implicate new risk genes and therapeutic targets for anxiety disorders
11天前
已完结
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
12天前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
1个月前
已完结
Whole transcriptome analysis reveals dysregulationof molecular networks in schizophrenia
3个月前
已完结
没有进行任何应助
感谢
10天前
感谢
10天前
感谢
10天前
感谢
11天前
感谢
11天前
感谢,点赞,速度真快,帮大忙了,么么哒
1个月前
感谢,速度真快,帮大忙了,么么哒
1个月前
感谢,点赞,速度真快,帮大忙了,么么哒
3个月前
感谢,点赞,速度真快,帮大忙了,么么哒
4个月前
感谢,点赞,速度真快,帮大忙了,么么哒
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论